Cardiac arrest is one of India’s biggest healthcare challenges—but not for long

With an unwavering mission to X out Angina from every individual, AnginaX AI is introducing India’s first in-house built Advanced AI Cardiologist’s Assistant—a system designed to empower doctors, hospitals, and clinics with precise, real-time cardiovascular insights.

On March 2, 2025, AnginaX AI begins its rollout across hospitals and clinics in India, giving doctors a powerful system to make informed heart health decisions from day one.

This is just the beginning. Throughout 2025, AnginaX will introduce a suite of interconnected products—building an ecosystem that seamlessly integrates into hospitals, clinics, and virtual healthcare.

Designed to enhance clinical decision-making, scale patient care, and streamline workflows, AnginaX is setting a new standard in cardiology—one that puts doctors in complete control.

AnginaX AI enables doctors to intervene in significantly more cases—without increasing workload. The system learns each physician’s style and method, adapting to their approach while delivering precise, individualized patient insights.

A Doctor’s Best Assistant – Not Just Another Prediction Tool

AnginaX AI is not a wearable, fitness tracker, or basic prediction model. Built on rigorous scientific research and biomarkers specific to the Indian population, it provides deeper, more relevant insights, giving doctors unparalleled clarity in cardiovascular assessment.

Designed for every doctor, hospital, and clinic, the system integrates seamlessly into any healthcare setting, whether in-person or through virtual platforms, making early intervention easier than ever.

By identifying underlying causes rather than just symptoms, AnginaX AI enables doctors to personalize care and intervene before it’s too late. The system is built for scale, ensuring that hospitals of all sizes—from large institutions to small clinics—can benefit from more effective heart care, whether in-person or through digital healthcare platforms.

"We Are Not Here to Predict Heart Disease. We Are Here to Stop It," said Naman Gosalia, Founder of AnginaX AI.

"Our mission is clear: to X out Angina from every individual. For too long, heart disease has been treated reactively—patients arrive in emergency rooms when it’s already too late. AnginaX AI is here to change that by becoming every doctor’s best assistant—giving them deeper insights, faster interventions, and the ability to treat causes before they turn into crises."

"With this rollout, hospitals and clinics will be able to intervene with double, even triple the efficiency—without increasing the burden on doctors. This isn’t just about reducing emergency admissions—it’s about creating a world where no family has to dial 108 in panic ever again. This isn’t just a product launch—it’s the beginning of a movement that will change heart health in India forever."

“The Future of Cardiology Starts Now," said Dr. Neeraj Desai, Chief Medical Catalyst & Cardiologist.

"Every heart is unique, and so is every patient. Heart disease isn’t a one-size-fits-all problem. AnginaX AI provides the clarity and depth doctors need to personalize treatment, intervene early, and prevent unnecessary hospitalizations."

Dr. V.N. Shah, Chief Medical Officer & Senior Diabetologist, emphasizes the link between diabetes and heart disease:

"Heart disease and diabetes are deeply connected, yet often treated in isolation. Many cardiac patients have undiagnosed diabetes, which silently accelerates arterial damage and increases heart attack risks. With AnginaX AI, doctors now have a system that integrates both cardiovascular and diabetes management—giving them precise, data-driven insights to detect risks earlier, intervene smarter, and prevent avoidable emergencies. This is the shift we need—not just for better patient care, but to reduce the overwhelming burden on hospitals."

A Smarter, More Scalable Approach to Heart Health

AnginaX AI equips physicians with real-time insights, allowing them to address heart disease before symptoms escalate. By tailoring heart health management based on each patient’s biomarkers, it enables more personalized care rather than generic prescriptions.

Designed for seamless integration into hospitals, clinics, and virtual healthcare platforms, AnginaX AI enhances accessibility and ensures that early intervention is prioritized over reactive treatment. Instead of merely predicting risks, the system focuses on preventing them altogether, offering a smarter approach to cardiovascular care.

With more products set to roll out in the coming months, AnginaX is leading a nationwide movement toward accessible and proactive heart health solutions.

Starting March 2, 2025, AnginaX AI will be available across hospitals and clinics in India, allowing doctors to prescribe heart health interventions with the first version of the system for a 30-day trial.

This Valentine’s Day, AnginaX AI Gives India the Ultimate Gift: A Future Without Heart Attacks
India’s First AI Cardiologist’s Assistant – Built for Doctors, Designed for Patients – Rolling Out to Hospitals and Clinics Across India on March 2

For media inquiries, partnerships, or prescription programs, contact: operations@anginax.ai